Navigation Links
CRESTOR(R) Now Indicated to Slow the Progression of Atherosclerosis in Patients With Elevated Cholesterol
Date:11/9/2007

WILMINGTON, Del., Nov. 9 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) announced today that the U.S. Food and Drug Administration (FDA) has approved CRESTOR(R) (rosuvastatin calcium) as an adjunct to diet to slow the progression of atherosclerosis in patients with elevated cholesterol. This new indication gives CRESTOR an important differentiator from competitors in the cholesterol-lowering marketplace.

"This new indication allows us to share what we've learned in clinical trials -- that even in people with low Framingham risk score, and early signs of atherosclerosis, the disease progresses if untreated," said Mike Tilton, AstraZeneca's Vice President of Cardiovascular Primary Care. "In the METEOR trial, patients with hyperlipidemia who took CRESTOR, overall experienced no significant progression of atherosclerosis."

The submission package to the FDA was based largely on the results of a pivotal study called METEOR (Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin) which measured the effects of CRESTOR on plaque build-up in the arteries using carotid intima-media thickness (CIMT) and demonstrated a slowing of progression of atherosclerosis in people with early signs of the disease, elevated LDL cholesterol, and low cardiovascular risk, taking CRESTOR 40 mg.

The METEOR study is part of AstraZeneca's GALAXY Program, a large, comprehensive, long-term and evolving global research initiative designed to address important unanswered questions in statin research and to investigate the impact of CRESTOR on cardiovascular risk reduction and patient outcomes. To date, the GALAXY Program has recruited more than 69,000 subjects in more than 55 countries around the world.

The new CRESTOR label conforms to the FDA's revised, easy-to-read format designed to draw physicians' attention to the most important pieces of drug information in an effort to manage the risks of medication use and reduce medical errors.

About
'/>"/>

SOURCE AstraZeneca
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Brain Lesions Predict MS Progression
2. Pregnancy may slow -- not accelerate -- progression to AIDS
3. Progression of SIV infection in monkeys raises
4. Chemotherapy with gemcitabine delays progression of operable pancreatic cancer
5. Limiting refined carbohydrates may stall AMD progression
6. New Data Suggests Progression of Disability at Two Years Predicts Multiple Sclerosis (MS) Disability Progression at Eight Years
7. Study finds genetic influence on pace of HIV/AIDS progression
8. Lifetime trauma may speed progression of HIV, early death
9. A new mathematical formula for cancer progression
10. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
11. Comparison of obstetric outcomes between on-call and patients own obstetricians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... ... article published August 12 by International Business Times, a new bill was signed ... in cases meant to decide if a police officer used deadly or excessive force in ... and New York City that absolved police officers of charges in the deaths of two ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... from the Abraham and Mildred Goldstein Charitable Trust to establish the Abraham and ... gift comes six months after WCHN recruited nationally known gynecologic oncologist Thomas J. ...
(Date:9/2/2015)... ... 02, 2015 , ... In “Failure Lab: Weight Loss Surgery was Never the ... writer Akela Stanfield detailed her lifelong struggle with obesity that eventually led her to ... seen herself as someone who would lose weight through sheer self-control, the dawning realization ...
(Date:9/2/2015)... ... September 02, 2015 , ... Healtec® LLC hired ... departure of Kristen Dietz, former Chief Operations Officer. Shaun Carpenter MD, FAPWCA, ... welcoming Mr. Salot: “ Stanley H. Salot Jr , our new President and ...
(Date:9/2/2015)... ... September 02, 2015 , ... Density measurement is used in ... sample handling makes density measurements more efficient and error-free. The new METTLER TOLEDO ... workflow and the advantages compared to manual sample handling. , The Evolution of ...
Breaking Medicine News(10 mins):Health News:Article on Recent Grand Jury Law Brings Increased Accountability to Wrongful Death Cases, says the Law Offices of Burg & Brock 2Health News:Article on Recent Grand Jury Law Brings Increased Accountability to Wrongful Death Cases, says the Law Offices of Burg & Brock 3Health News:Western Connecticut Health Network Receives $1 Million Gift to Establish Ovarian Cancer Research Endowment 2Health News:Western Connecticut Health Network Receives $1 Million Gift to Establish Ovarian Cancer Research Endowment 3Health News:Recent Editorial on Bariatric Surgery Acceptance Illuminates a Typical Journey Towards Weight Loss Surgery, Notes Dr. Michael Feiz 2Health News:Healtec® Announces Executive Leadership Change 2Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 2Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 3
... CONSHOHOCKEN, Pa., March 13 Apollo Health Street has ... Payer segment in the prestigious Black Book of Outsourcing ... Apollo Health Street, states, "We appreciate the recognition from ... is an independent validation of our commitment to excellence.""The ...
... Human Genome Sciences, Inc. (Nasdaq: HGSI ... and Company 29th Annual Health Care Conference will be ... http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO ) , A member of Human ... overview on Wednesday, March 18, 2009 from 8:45 to ...
... PHILADELPHIA, March 13 Lead Counsel for Plaintiffs in ... the following:, UNITED STATES DISTRICT COURT, ... IN RE: SCHERING-PLOUGH CORPORATION SECURITIES LITIGATION, ... , ATTENTION PURCHASERS OF SCHERING-PLOUGH CORPORATION SECURITIES ...
... Bank, N.A.BASKING RIDGE, N.J., March 13 Hooper Holmes (Amex: ... fourth quarter and year ended December 31, 2008. For the ... to $47.4 million compared to $51.4 million in the fourth ... $1.2 million for the fourth quarter of 2008, or $0.02 ...
... up your keys has its down sideSAN FRANCISCO, March 13 ... Gerontology (Medical Sciences) indicate that convincing older drivers to give ... idea.The study of 660 adults aged 63 to 97 showed ... more likely to die over a three-year period than their ...
... Stock Exchange Bell-Ringing, Yoko Ono Lennon Event at the UN, ,and ... ... New York, NY (PRWEB) March 13, 2009 -- Autism ... a series of national and international events to mark the second ...
Cached Medicine News:Health News:Apollo Health Street Has Earned the Number One Spot in the Healthcare Payer Segment for BPO Services 2Health News:Settlement Hearing on Schering-Plough Corporation Securities Litigation to be Held on June 1, 2009 at 2:00 P.M. 2Health News:Settlement Hearing on Schering-Plough Corporation Securities Litigation to be Held on June 1, 2009 at 2:00 P.M. 3Health News:Settlement Hearing on Schering-Plough Corporation Securities Litigation to be Held on June 1, 2009 at 2:00 P.M. 4Health News:Hooper Holmes Announces Fourth Quarter and Year-End 2008 Results 2Health News:Hooper Holmes Announces Fourth Quarter and Year-End 2008 Results 3Health News:Hooper Holmes Announces Fourth Quarter and Year-End 2008 Results 4Health News:Hooper Holmes Announces Fourth Quarter and Year-End 2008 Results 5Health News:Hooper Holmes Announces Fourth Quarter and Year-End 2008 Results 6Health News:Hooper Holmes Announces Fourth Quarter and Year-End 2008 Results 7Health News:Hooper Holmes Announces Fourth Quarter and Year-End 2008 Results 8Health News:Drive or Die 2Health News:Drive or Die 3Health News:Autism Speaks Celebrates Second Annual World Autism Awareness Day with an Array of International Events on April 2 2Health News:Autism Speaks Celebrates Second Annual World Autism Awareness Day with an Array of International Events on April 2 3Health News:Autism Speaks Celebrates Second Annual World Autism Awareness Day with an Array of International Events on April 2 4Health News:Autism Speaks Celebrates Second Annual World Autism Awareness Day with an Array of International Events on April 2 5
(Date:9/2/2015)... BEIJING , Sept. 2, 2015 ... or the "Company"), a leading fully integrated plasma-based ... today announced that the Company,s subsidiary Guizhou Taibang ... a strategic collaboration agreement (the "Agreement") with Xinjiang ... raw plasma. The Agreement allows Guizhou Taibang to ...
(Date:9/2/2015)... , Sept. 2, 2015  Valeant Pharmaceuticals International, Inc. ... that its affiliate has entered into a definitive agreement ... , Inc. (NASDAQ: SURG ) for $6.50 ... cash payment, Synergetics stockholders will receive additional cash payments ... milestones are achieved following the closing.  The transaction is ...
(Date:9/2/2015)... Sept. 2, 2015 Delcath Systems, Inc. (NASDAQ: ... company focused on oncology with an emphasis on the ... Company management will participate in the upcoming 17 th ... September 8-10, 2015 at the St. Regis Hotel in ... CRNP, Delcath,s President and Chief Executive Officer, will present ...
Breaking Medicine Technology:China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 2China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 3China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 4China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 5Valeant Pharmaceuticals To Acquire Synergetics USA 2Valeant Pharmaceuticals To Acquire Synergetics USA 3Valeant Pharmaceuticals To Acquire Synergetics USA 4Valeant Pharmaceuticals To Acquire Synergetics USA 5Delcath To Present At The 17th Annual Rodman & Renshaw Conference 2Delcath To Present At The 17th Annual Rodman & Renshaw Conference 3
... Corporation (OTCQB: CTIX) today reported that its flagship cancer ... treatment of leukemia cells in a hematopoietic xenograft tumor ... reactivation of p53, the "Guardian Angel" protein, which Cellceutix ... research.   The data was presented to ...
... presentations to be delivered at the Drug Information Association ... in Geneva, Switzerland, experts from PAREXEL International ... biopharmaceutical services provider, will address advanced approaches to help ... marketplace. Experts from PAREXEL will be available ...
Cached Medicine Technology:Cellceutix Discovers Drug Activates 'Guardian Angel p53' in Fight Against Leukemia 2Cellceutix Discovers Drug Activates 'Guardian Angel p53' in Fight Against Leukemia 3PAREXEL Experts to Present Advanced Approaches to Accelerate Development, Maximize Product Value at DIA EuroMeeting 2PAREXEL Experts to Present Advanced Approaches to Accelerate Development, Maximize Product Value at DIA EuroMeeting 3PAREXEL Experts to Present Advanced Approaches to Accelerate Development, Maximize Product Value at DIA EuroMeeting 4
Merocel Ophthalmic Products provide the surgeon with fiber free products for fluid,control and safe cleaning of fine microsurgical instruments. The exclusive Merocel,material is highly absorbent,...
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
Medicine Products: